Armistice Capital »

Soligenix shares owned by Armistice Capital

Quarter-by-quarter ownership of Soligenix (SNGX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Soligenix

Tip: Access up to 7 years of quarterly data

All positions including Soligenix held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soligenix by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $206k 80k 2.58

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Soligenix

Armistice Capital
Stephens
Geode Capital Management
Tower Research Capital
Plante Moran Financial Advisors
Morgan Stanley
Bank of America Corporation
Albion Financial Group

View all funds holding Soligenix